|1.||Wei, Huanhuan: 1 article (02/2012)|
|2.||Zhang, Ling: 1 article (02/2012)|
|3.||Wang, Huijie: 1 article (02/2012)|
|4.||Wei, Xiaoyi: 1 article (02/2012)|
|5.||Ruan, Yuanyuan: 1 article (02/2012)|
|6.||Xu, Liangxiong: 1 article (02/2012)|
|7.||Yu, Min: 1 article (02/2012)|
|2.||Breast Neoplasms (Breast Cancer)
02/13/2012 - "These results suggest that monocillin II has potential therapeutic benefits in breast cancer prevention and intervention."
02/13/2012 - "Monocillin II inhibits human breast cancer growth partially by inhibiting MAPK pathways and CDK2 Thr160 phosphorylation."
02/13/2012 - "We demonstrated for the first time that monocillin II could arrest breast cancer cell cycle in G1 phase, which might partially be the result of its inhibition effect on the phosphorylation of the Thr160 residue of cyclin dependent kinase 2 (CDK2), a key enzyme in cell-cycle regulation. "
|1.||Cyclin-Dependent Kinase 2